"Target Identification and New Screening Applications"
08:00 |
08:30 |
Registration |
|
|
08:30 |
08:35 |
Welcome by the Chairman of ELRIG.de e.V. |
Tobias May |
Elrig.de e.V. |
08:35 |
09:10 |
Keynote presentation: Artificial Intelligence in Drug Discovery |
Gerhard Hessler |
Sanofi, Frankfurt, D |
09:10 |
09:35 |
Energy transfer as a general approach to assess target occupancy and residence time for kinase inhibitors and PROTACs in living cells |
Matt Robers |
Promega, USA |
09:35 |
10:00 |
Proteomics for target and pathway deconvolution |
Hannes Hahne |
OmicScouts, Freising, D |
10:00 |
10:25 |
Cytomegalovirus dynamics at the single-cell level |
Ulfert Rand |
Helmholtz Zentrum f. Infektionsforschung, Braunschweig, D |
10:25 |
10:45 |
Coffee break & Poster session |
|
|
10:45 |
11:10 |
CETSA ®enabled Drug Discovery |
Michael Dabrowski |
Pelago Bioscience, Solna, S |
11:10 |
11:35 |
Towards higher content for early Drug Discovery: Target engagement analysis by NanoBret | Birgitta Leuthner |
Merck, Darmstadt, D |
11:35 |
12:00 |
Target Identification and Validation using CRISPR Technology |
Hauke Cornils |
Evotec, Hamburg, D |
12:00 |
12:25 |
Patient iPSC derived disease models in drug development
|
Ulf Nehrbass |
Ksilink, Straßburg, F |
12:25 |
14:00 |
Lunch Break & Poster Session |
|
|
14:00 |
14:25 |
MS-based chemoproteomic approaches for target identification and validation |
Stefan Müller |
Evotec, München, D |
14:25 |
14:50 |
From Discovery to Formulation. Biophysics in Drug Development. |
Beate Kern |
Nanotemper, München, D |
14:50 |
15:15 |
Advanced Biological Screening |
Holger Erfle |
Bioquant, Heidelberg, D |
15:15 |
15:45 |
Coffee break & Poster Session |
|
|
15:45 |
16:10 |
Towards the implementation of perfused co-cultures in screening |
Florian Fuchs |
Novartis, Basel, CH |
16:10 |
16:35 |
High throughput solutions for cardiac drug and safety research |
Elena Dragicevic |
Nanion Technologies, München, D |
16:35 |
17:00 |
Wrap up Forum 2019 |
|
|